Skip to main content
Premium Trial:

Request an Annual Quote

ABI/MDS Sciex Sell 21 Mass Specs to CDC, State Health Labs

NEW YORK, Oct. 3 (GenomeWeb News) - Applied Biosystems and its joint venture partner MDS Sciex have sold 21 mass spectrometry systems to the Centers for Disease Control and Prevention and several state health laboratories as part of their Laboratory Response Network, a nationwide network of labs to detect biological and chemical threats, ABI said today.

 

The labs will use the API 4000 LC/MS/MS systems to identify toxic chemicals in human blood or urine samples.

 

ABI has already supplied real-time PCR systems to the Laboratory Response Network for biological detection, according to the company.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.